Related Experiment Video
Updated: Jul 13, 2026

08:09
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
A novel strategy to mimic discontinuous protective epitopes using a synthetic scaffold
Marcel Hijnen1, Dirk J van Zoelen, Cristina Chamorro
1Laboratory for Vaccine Preventable Diseases, National Institute of Public Health and the Environment, Antonie van Leeuwenhoeklaan 1, PO Box 1, Bilthoven, The Netherlands.
Vaccine
|August 11, 2007
Summary
Fully synthetic vaccines are now possible using a novel scaffold to mimic complex protein structures. This breakthrough enables the creation of new vaccines that can elicit protective antibodies against diseases.
Area of Science:
- Vaccinology
- Synthetic chemistry
- Immunology
Background:
- Traditional vaccines have limitations in mimicking complex native protein structures.
- Linear synthetic peptides struggle to replicate the precise shapes of epitopes needed for antibody induction.
- Fully synthetic vaccines remain an unrealized goal in vaccinology.
Purpose of the Study:
- To develop a novel synthetic scaffold capable of presenting peptide fragments in a conformationally defined manner.
- To demonstrate the potential of this scaffold in creating fully synthetic vaccines.
- To induce protective antibodies against a discontinuous epitope using a synthetic construct.
Main Methods:
- Utilized Bordetella pertussis pertactin as a model antigen.
- Designed and synthesized a novel scaffold to present multiple peptide arms.
- Employed computational modeling to guide the construct design.
- Tested the immunogenicity of the synthetic construct in inducing antibodies.
Main Results:
- Successfully created a synthetic construct presenting peptide arms on a novel scaffold.
- The synthesized construct mimicked a structurally defined, discontinuous epitope.
- The construct successfully induced protective antibodies targeting the discontinuous epitope.
- Demonstrated proof-of-concept for a new approach to synthetic vaccine design.
Conclusions:
- A novel synthetic scaffold can accurately mimic complex epitopes.
- This approach overcomes limitations of linear peptides in vaccine design.
- Fully synthetic vaccines capable of inducing protective antibodies are now achievable.
- Opens new avenues for designing next-generation vaccines.

